Overall, these results suggest that COPD-EVs promote the increase of CD133+ cancer-initiating cells, in particular through the expansion of CD133+CXCR4+ MICs subset, along with the acquisition of pro-tumorigenic and invasive properties in HBEC-KRASV12high cells. The gene discussed is CXCR4; the disease is cancer.